Combo Device Strategies: Pathways to Market

On September 18, Bill Geary will be presenting on a panel for M2D2 - UMass Lowell's "Combo Drug & Device Strategies: Pathways to Market" event. This engaging event brings together key voices from the healthcare and life sciences sectors. The speakers will delve into the complexities and strategic considerations involved in bringing combination drug-device products to market.

Industry veterans and regulatory authorities will lead a thought-provoking discussion on the latest developments in regulatory frameworks, clinical validation processes, reimbursement strategies, and collaboration models. Gain practical insights and connect with peers navigating the evolving landscape of combination therapies.

In addition to the expert panel, there will be live pitches from trailblazing companies developing next-generation combination products. These innovators will showcase their technologies and share firsthand experiences navigating the complex journey from concept to commercialization - including securing investment, overcoming regulatory challenges, and positioning their products for market success.